Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Day One Biopharmaceuticals (DAWN) Leases (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Leases for 4 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • For Q4 2025, Leases fell 3.3% year-over-year to $2.3 million; the TTM value through Dec 2025 reached $2.3 million, down 3.3%, while the annual FY2025 figure was $2.3 million, 3.3% down from the prior year.
  • Leases was $2.3 million for Q4 2025 at Day One Biopharmaceuticals, down from $2.4 million in the prior quarter.
  • The five-year high for Leases was $2.6 million in Q1 2025, with the low at $164000.0 in Q2 2024.
  • Historically, Leases has averaged $1.2 million across 4 years, with a median of $781500.0 in 2022.
  • The largest annual shift saw Leases tumbled 69.06% in 2024 before it skyrocketed 1423.78% in 2025.
  • Over 4 years, Leases stood at $699000.0 in 2022, then crashed by 49.64% to $352000.0 in 2023, then surged by 588.07% to $2.4 million in 2024, then fell by 3.3% to $2.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Leases were $2.3 million in Q4 2025, $2.4 million in Q3 2025, and $2.5 million in Q2 2025.